Mika Takai
Overview
Explore the profile of Mika Takai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takai M, Shimada K, Furukawa K, Yamaga Y, Yoshiyama S, Kagaya Y, et al.
Cancer Sci
. 2024 Oct;
116(1):214-225.
PMID: 39428323
Intravascular large B-cell lymphoma (IVLBCL) is a rare type of extranodal large B-cell lymphoma that is characterized by the proliferation of lymphoma cells in the lumina of small vessels. Recent...
2.
Sahashi S, Shimada K, Takagi Y, Aoki T, Kunou S, Sakamoto A, et al.
Int J Hematol
. 2023 May;
118(2):221-230.
PMID: 37129802
Patient-derived xenograft (PDX) mouse models are useful for deepening our understanding of the biology of malignant lymphoma; however, factors associated with the success of the PDX lymphoma model are largely...
3.
Kunou S, Shimada K, Takai M, Sakamoto A, Aoki T, Hikita T, et al.
Oncogene
. 2021 May;
40(23):3989-4003.
PMID: 33994542
The tumor microenvironment is deeply involved in the process of tumor growth and development. In this study, we focused on cancer-associated fibroblasts (CAFs) and their derived exosomes on the lymphoma...
4.
Kumazoe M, Takai M, Hiroi S, Takeuchi C, Yamanouchi M, Nojiri T, et al.
Sci Rep
. 2017 May;
7(1):1917.
PMID: 28507327
Recurrence following chemotherapy is observed in the majority of patients with pancreatic ductal adenocarcinoma (PDAC). Recent studies suggest that cancer stem cells (CSCs) may be involved in PDAC recurrence and...
5.
Kumazoe M, Takai M, Hiroi S, Takeuchi C, Kadomatsu M, Nojiri T, et al.
J Biol Chem
. 2017 May;
292(26):10813-10823.
PMID: 28507102
In 95% of patients with pancreatic ductal adenocarcinoma, recurrence is observed following chemotherapy. Findings from several studies have indicated that cancer stem cells (CSCs) are resistant to anticancer agents and...
6.
Huang Y, Kumazoe M, Bae J, Yamada S, Takai M, Hidaka S, et al.
Oncol Rep
. 2015 Jul;
34(3):1162-8.
PMID: 26135316
An epidemiological study showed that green tea consumption is associated with a reduced risk of hematopoietic malignancy. The major green tea polyphenol epigallocatechin‑3-O-gallate (EGCG) is reported to have anticancer effects....
7.
Kumazoe M, Fujimura Y, Hidaka S, Kim Y, Murayama K, Takai M, et al.
Sci Rep
. 2015 Apr;
5:9474.
PMID: 25824377
Green tea extract (GTE) induces apoptosis of cancer cells without adversely affecting normal cells. Several clinical trials reported that GTE was well tolerated and had potential anti-cancer efficacy. Epigallocatechin-3-O-gallate (EGCG)...
8.
Takai M, Miyazaki Y, Tachibana H, Yamada K
Biosci Biotechnol Biochem
. 2014 Oct;
78(10):1743-7.
PMID: 25273140
In this study, we revealed that a Mekabu (Udaria pinnantifida) extract enhanced immunoglobulin (Ig) production of mouse spleen lymphocytes. Furthermore, it was suggested that water-soluble and high molecular weight ingredients...
9.
Kumazoe M, Kim Y, Bae J, Takai M, Murata M, Suemasu Y, et al.
FEBS Lett
. 2013 Aug;
587(18):3052-7.
PMID: 23916810
(-)-Epigallocatechin-3-O-gallate (EGCG), a polyphenol in green tea, induces apoptosis in acute myeloid leukemia (AML) cells without affecting normal cells. In this study, we observed that cGMP acts as a cell...
10.
Ito T, Oishi S, Takai M, Kimura Y, Uozumi Y, Fujio Y, et al.
J Biomed Sci
. 2010 Sep;
17 Suppl 1:S20.
PMID: 20804595
Taurine, a sulfur-containing beta-amino acid, is highly contained in heart and skeletal muscle. Taurine has a variety of biological actions, such as ion movement, calcium handling and cytoprotection in the...